BMP Type II Receptor as a Therapeutic Target in Pulmonary Arterial Hypertension

Cellular and Molecular Life Sciences - Switzerland
doi 10.1007/s00018-017-2510-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension

International Journal of Rheumatology
RheumatologyImmunology
2010English

Iron Deficiency in Pulmonary Arterial Hypertension: A Potential Therapeutic Target

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Role of Bone Morphogenetic Protein Type II Receptor Signaling in Pulmonary Arterial Hypertension

Cardiovascular Pharmacology: Open Access
2013English

Diagnostic and Therapeutic Algorithm for Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2011English

Is Inflammation a Potential Therapeutic Target in Chronic Thromboembolic Pulmonary Hypertension?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Downregulation of Type II Bone Morphogenetic Protein Receptor in Hypoxic Pulmonary Hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2005English

Prostanoid Receptor EP2 as a Therapeutic Target

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

Pulmonary Arterial Hypertension in Glycogen Storage Disease Type I

Journal of Inborn Errors of Metabolism and Screening
Child HealthGeneticsEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2017English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy